Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pharmanutra S.p.A
PHNCurrent price
56.5 EUR
-0.3 EUR (-0.53%)
Last closed
57 EUR
Company
www.pharmanutra.it
ISIN
IT0005274094
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Borsa Italiana
Capitalization
517 027 395 EUR
Yield for 12 month
+9.28 %
1Y
3Y
5Y
10Y
15Y
PHN
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company's products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Cetilar Tape, Cetilar Oro, Cetilar Nutrition, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. The company was founded in 2003 and is based in Pisa, Italy. Address: Via Campodavela 1, Pisa, PI, Italy, 56122
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
75.92 EURP/E ratio
35.3642Dividend Yield
1.53 %Current Year
+100 976 264 EUR
Last Year
+84 038 388 EUR
Current Quarter
+33 209 644 EUR
Last Quarter
+24 226 765 EUR
Current Year
+61 718 242 EUR
Last Year
+30 400 101 EUR
Current Quarter
+14 370 188 EUR
Last Quarter
+7 180 055 EUR
Key Figures PHN
1 year
3 years
5 years
10 years
EBITDA
27 015 146 EUR
Operating Margin TTM
PE Ratio
35.3642
Return On Assets TTM
14.04 %
PEG Ratio
–
Return On Equity TTM
28.01 %
Wall Street Target Price
75.92 EUR
Revenue TTM
108 436 467 EUR
Book Value
5.75 EUR
Revenue Per Share TTM
Dividend Share
0.86 EUR
Quarterly Revenue Growth YOY
24.7 %
Dividend Yield
1.53 %
Gross Profit TTM
29 724 924 EUR
Earnings per share
1.52 EUR
Diluted Eps TTM
1.52 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
146.4 %
Profit Margin
13.47 %
Dividend Analytics PHN
Dividend growth over 5 years
142 %Continuous growth
4 yearsPayout Ratio 5 years average
40 %Dividend History PHN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.85
Ex Dividend Date
06.05.2024
Forward Annual Dividend Yield
1.58 %
Last Split Factor
–
Payout Ratio
68.23 %
Last Split Date
–
Dividend Date
–
Stock Valuation PHN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
35.3642
Forward PE
–
Enterprise Value Revenue
4.8314
Price Sales TTM
4.768
Enterprise Value EBITDA
18.3066
Price Book MRQ
9.4489
Financials PHN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PHN
For 52 weeks
45.2 EUR
62.95 EUR
50 Day MA
56.84 EUR
Shares Short Prior Month
–
200 Day MA
53.98 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart